Magnetic Resonance Imaging of Prostate Cancer: Diffusion-Weighted Imaging in Comparison With Sextant Biopsy

Purpose: To retrospectively evaluate the impact of diffusion-weighted imaging (DWI) on the detection of prostate cancer in comparison with sextant biopsy. Materials and Methods: Fifty patients with clinical suspicion of prostate cancer underwent a combined endorectal-body-phased array magnetic resonance imaging examination at a 1.5 T magnetic resonance imaging (Siemens, Erlangen, Germany). The DWI was performed using b values of 50, 400, 800 s/mm2. The prostate was divided into sextants, including the apex, the middle aspect, and the base for the left and right sides, separately. Regions of interest were placed in the peripheral zone of each sextant to evaluate the apparent diffusion coefficient (ADC) values. The results of the DWI were compared side by side with the findings of the histological examination of endorectal sonographically guided sextant biopsy. The sensitivity and specificity of ADC for the identification of the tumor tissue were computed for variable discrimination thresholds to evaluate its receiver operating characteristic. An association between ADC and Gleason score was tested for both the whole study group and on an individual basis using the nonparametric Spearman &rgr; test and the Pearson correlation, respectively. Results: Histopathology identified tumor tissue in 21 (42%) of the 50 patients. The ADC value was 1.65 ± 0.32 mm2/s 10−3 in normal tissue and 0.96 ± 0.24 mm2/s 10−3 in tumor tissue (mean ± 1 SD). The area under the receiver operating characteristic curve was 0.966. Using the discrimination threshold 1.21 mm2/s 10−3, for example, the ADC value provided a sensitivity of 0.92 and a specificity of 0.93. There was a highly significant negative correlation between the ADC value and the Gleason score in the tumor-positive tissue probes (n = 62, &rgr; = −0.405, P = 0.001) in the whole study group. On the individual patient basis, the Pearson correlation revealed a mean coefficient of r = −0.89 (SD ± 0.12) with a P < 0.001. Conclusions: Diffusion-weighted imaging of the prostate can be used to differentiate benign from malignant tissue in the peripheral zone. In the present study, ADC values were significantly lower in prostate cancer than in benign tissue.

[1]  P H Bland,et al.  Prostate cancer: correlation of MR images with tissue optical density at pathologic examination. , 1991, Radiology.

[2]  K. Taari,et al.  Endorectal magnetic resonance imaging of prostatic cancer: comparison between fat-suppressed T2-weighted fast spin echo and three-dimensional dual-echo, steady-state sequences , 2001, European Radiology.

[3]  Jean-Luc Daire,et al.  Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. , 2003, Radiology.

[4]  M. Meng,et al.  Imaging clinically localized prostate cancer. , 2003, The Urologic clinics of North America.

[5]  P. Carroll,et al.  Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal--pelvic phased-array coils. , 1994, Radiology.

[6]  Cher Heng Tan,et al.  Diffusion weighted imaging in prostate cancer , 2011, European Radiology.

[7]  Katsuyoshi Ito,et al.  Apparent diffusion coefficient values in peripheral and transition zones of the prostate: Comparison between normal and malignant prostatic tissues and correlation with histologic grade , 2008, Journal of magnetic resonance imaging : JMRI.

[8]  K. Taari,et al.  Prostatic MR imaging: Accuracy in differentiating cancer from other prostatic disorders , 2001, Acta radiologica.

[9]  H. Shinmoto,et al.  Prostate cancer screening: The clinical value of diffusion‐weighted imaging and dynamic MR imaging in combination with T2‐weighted imaging , 2007, Journal of magnetic resonance imaging : JMRI.

[10]  A. Hemal,et al.  Apparent diffusion coefficient of the prostate in men prior to biopsy: determination of a cut‐off value to predict malignancy of the peripheral zone , 2007, NMR in biomedicine.

[11]  B. Issa,et al.  In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo‐planar imaging , 2002, Journal of magnetic resonance imaging : JMRI.

[12]  A. Thompson,et al.  MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters. , 2009, AJR. American journal of roentgenology.

[13]  Takeo Ishigaki,et al.  Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate , 2005, Journal of magnetic resonance imaging : JMRI.

[14]  J. D. de Certaines,et al.  Proton NMR relaxation times of experimental Lewis lung carcinoma after irradiation. , 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  E. Negri,et al.  Leveling of prostate cancer mortality in Western Europe , 2004, The Prostate.

[16]  K. Hayashi,et al.  Diffusion-weighted echoplanar MR imaging of the salivary glands. , 2002, AJR. American journal of roentgenology.

[17]  B. Hamm,et al.  Histopathologische Qualität von Prostatastanzzylindern: Vergleich einer MR-kompatiblen Biopsienadel mit einer im Ultraschall eingesetzten ferromagnetischen Biopsienadel , 2006 .

[18]  J R Thornbury,et al.  Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. , 1997, Radiology.

[19]  J. García-Segura,et al.  Comparison of digital rectal examination, transrectal ultrasonography, and multicoil magnetic resonance imaging for preoperative evaluation of prostate cancer. , 1997, European urology.

[20]  M. Matoba,et al.  Lung carcinoma: diffusion-weighted mr imaging--preliminary evaluation with apparent diffusion coefficient. , 2007, Radiology.

[21]  Matthew J Hayat,et al.  Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. , 2007, The oncologist.

[22]  Takeo Ishigaki,et al.  Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging. , 2007, European journal of radiology.

[23]  K. Hosseinzadeh,et al.  Endorectal diffusion‐weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue , 2004, Journal of magnetic resonance imaging : JMRI.

[24]  G. P. Krestin,et al.  Präoperatives T-Staging des Prostatakarzinoms: Endorektale Magnetresonanztomographie im Vergleich zu anderen biidgebenden und klinischen Methoden , 1996 .

[25]  T. Vogl,et al.  Staging des Prostatakarzinoms: Wertigkeit der kombinierten Information aus endorektaler MRT, bioptischem Gleason Score und präoperativem PSA-Wert , 2006 .

[26]  A. Wetter,et al.  [Staging of prostate cancer: value of the combined information of endorectal MRI, biopsy Gleason score, and preoperative PSA level]. , 2006, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[27]  G. Krestin,et al.  [Preoperative T-staging of prostatic carcinoma: endorectal magnetic resonance tomography compared with other imaging and clinical methods]. , 1996, RöFo. Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren (Print).

[28]  S. Kyriazi,et al.  Evaluation of the potential of diffusion-weighted imaging in prostate cancer detection , 2007, Acta radiologica.

[29]  B. Carey,et al.  Imaging for prostate cancer. , 2005, Clinical oncology (Royal College of Radiologists (Great Britain)).

[30]  P. Carroll,et al.  Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. , 1996, Radiology.

[31]  Jason A Koutcher,et al.  Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings. , 2008, Radiology.

[32]  D. Le Bihan,et al.  Artifacts and pitfalls in diffusion MRI , 2006, Journal of magnetic resonance imaging : JMRI.

[33]  Jelle O. Barentsz,et al.  Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis , 2002, European Radiology.